(Q33818767)

29 July 2017

1 reference

title

The targets of the lytic antibody response against Trypanosoma cruzi (English)

1 reference

29 July 2017

0 references

3

Krettli AU

1 reference

ORCID Public Data File 2021

29 July 2017

1 reference

author name string

Krautz GM

series ordinal

1

1 reference

29 July 2017

Kissinger JC

series ordinal

2

1 reference

29 July 2017

language of work or name

1 reference

1 January 2000

1 reference

29 July 2017

published in

Trends in Parasitology

1 reference

29 July 2017

volume

16

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

31-34

1 reference

Studies on the selective lysis and purification of Trypanosoma cruzi

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Transformation of trypomastigote forms of Trypanosoma cruzi into activators of alternative complement pathway by immune IgG fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Trypanosoma cruzi: different surface antigens of trypomastigotes are targets of lytic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Diagnosis of Trypanosoma cruzi chronic infections in humans: usefulness of the complement regulatory protein antigens and lytic antibodies in the control of cure

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Natural human immunity to trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Monoclonal antibodies against the flagellar fraction of epimastigotes of Trypanosoma cruzi: complement-mediated lytic activity against trypomastigotes and passive immunoprotection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Structural and functional properties of Trypanosoma trans-sialidase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

FL-160 proteins of Trypanosoma cruzi are expressed from a multigene family and contain two distinct epitopes that mimic nervous tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

Trypanosoma cruzi: recognition of trypomastigote surface antigens by lytic antisera from mice resistant to acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901581-1

7 January 2021

10.1016/S0169-4758(99)01581-1

Identifiers

DOI

1 reference

29 July 2017

1 reference